Valuation: Valbiotis

Market Cap 1.79Cr 2.06Cr 1.67Cr 1.53Cr 2.89Cr 195.89Cr 2.94Cr 20Cr 7.7Cr 98Cr 7.72Cr 7.55Cr 322.2Cr P/E 2026 *
-2.42x
P/E 2027 * -9.44x
Enterprise Value 1.91Cr 2.19Cr 1.78Cr 1.63Cr 3.08Cr 209.05Cr 3.13Cr 21Cr 8.22Cr 104.25Cr 8.24Cr 8.06Cr 343.85Cr EV / Sales 2026 *
4.95x
EV / Sales 2027 * 1.19x
Free-Float
97.31%
Yield 2026 *
-
Yield 2027 * -
1 day+0.66%
1 week-1.30%
Current month-1.30%
1 month-7.32%
3 months-18.28%
6 months-37.09%
Current year+9.51%
1 week 0.74
Extreme 0.74
0.8
1 month 0.74
Extreme 0.74
0.86
Current year 0.65
Extreme 0.653
1.3
1 year 0.54
Extreme 0.535
1.3
3 years 0.54
Extreme 0.535
7.5
5 years 0.54
Extreme 0.535
7.5
10 years 0.54
Extreme 0.535
10.65
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 01/03/2024
Chief Tech/Sci/R&D Officer - 01/09/2017
Director TitleAgeSince
Chairman 55 01/03/2017
Director/Board Member - 26/10/2017
Director/Board Member - 18/03/2019
Date Insider Type Main position Quantity % Market Cap.
28/01/22 Others

Founder

42,480 0.4364%
28/01/22 Fiscal year

Founder

2,095 0.0215%
10/07/21 Fiscal year

Chief Technology Officer

2,000 0.0206%
Change 5-day change 1-year change 3-year change Capi.($)
+0.66%-1.30%-3.80%-81.46% 2.06Cr
+0.05%+3.08%+38.17%+66.77% 5.67TCr
+0.69%-5.80%+23.76%+62.47% 5.2TCr
+0.50%-0.54%-16.43%-13.65% 2.33TCr
+0.36%-5.84%-11.86%+345.88% 2.13TCr
+1.98%-1.60%+32.78%-25.82% 1.74TCr
+9.91%-2.51%+188.84%+326.19% 1.48TCr
+1.43%-1.73%+50.86%+173.95% 1.38TCr
+1.44%+0.78%+425.05%+173.14% 1.21TCr
+3.43%-8.27%+58.36%+154.14% 1.11TCr
Average +2.09%-2.42%+78.57%+118.16% 2.23TCr
Weighted average by Cap. +1.44%-1.95%+56.71%+110.86%

Financials

2026 *2027 *
Net sales 38.5L 44.3L 35.94L 33L 62.22L 42Cr 63.3L 4.24Cr 1.66Cr 21Cr 1.66Cr 1.63Cr 69Cr 1.32Cr 1.52Cr 1.24Cr 1.14Cr 2.14Cr 145.32Cr 2.18Cr 15Cr 5.71Cr 72Cr 5.73Cr 5.6Cr 239.02Cr
Net income -87.5L -1.01Cr -81.69L -74.99L -1.41Cr -96Cr -1.44Cr -9.63Cr -3.77Cr -48Cr -3.78Cr -3.7Cr -157.84Cr -53.5L -61.56L -49.95L -45.85L -86.46L -59Cr -87.97L -5.89Cr -2.31Cr -29Cr -2.31Cr -2.26Cr -97Cr
Net Debt 12L 13.81L 11.2L 10.28L 19.39L 13Cr 19.73L 1.32Cr 51.74L 6.56Cr 51.86L 50.71L 22Cr -21L -24.16L -19.61L -18L -33.94L -23Cr -34.53L -2.31Cr -90.54L -11Cr -90.76L -88.75L -38Cr
Logo Valbiotis
VALBIOTIS is a French laboratory specializing in the creation and distribution of dietary supplements scientifically tested to maintain health at every stage of life. Through an innovative approach combining scientific excellence, plant expertise and a wealth of natural ingredients, VALBIOTIS offers a new generation of dietary supplements to support cardio-metabolic balance and well-being, and address everyday health issues such as sleep, fatigue, mood management, immunity and vitality.
Employees
50
Date Price Change Volume
04/26/04 0.7600 +0.66% 86,112
03/26/03 €0.7550 -1.95% 94,519
31/26/31 €0.7700 -0.26% 50,109
30/26/30 €0.7720 +1.58% 35,717
29/26/29 €0.7600 -1.30% 61,117
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.7550EUR
Average target price
2.228EUR
Spread / Average Target
+195.05%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALVAL Stock